Skip to main content

Peer Review reports

From: The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration - a phase IV randomised clinical trial with ranibizumab: the FLUID study

Original Submission
9 Jul 2015 Submitted Original manuscript
27 Jul 2015 Author responded Author comments - Jennifer Arnold
31 Jul 2015 Reviewed Reviewer Report - Haoyu Chen
20 Dec 2015 Reviewed Reviewer Report - Marc Biarnés
Resubmission - Version 2
27 Jul 2015 Submitted Manuscript version 2
29 Jan 2016 Author responded Author comments - Jennifer Arnold
17 Feb 2016 Reviewed Reviewer Report - Haoyu Chen
Resubmission - Version 3
29 Jan 2016 Submitted Manuscript version 3
Publishing
11 Mar 2016 Editorially accepted
24 Mar 2016 Article published 10.1186/s12886-016-0207-3

You can find further information about peer review here.

Back to article page